Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Severe Malaria and Anti-malarial Drug Resistance in Cambodia

This study has been completed.
Sponsor:
Information provided by:
National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier:
NCT00341003
First received: June 19, 2006
Last updated: September 26, 2015
Last verified: January 2011